Literature DB >> 24383714

Bisphosphonates and cardiac electrophysiology: should the red flag be raised higher?

Jérôme Kalifa1, Uma Mahesh R Avula.   

Abstract

Entities:  

Keywords:  arrhythmia; atrial fibrillation; bisphosphonates; ibandronate; osteoporosis

Mesh：

Substances：

Year:  2014        PMID： 24383714      PMCID： PMC4189830          DOI： 10.1111/jce.12349

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


× No keyword cloud information.
  3 in total

Review 1.  Impact of bisphosphonates on the risk of atrial fibrillation.

Authors:  Patricia A Howard; Brian J Barnes; James L Vacek; Warren Chen; Sue-Min Lai
Journal:  Am J Cardiovasc Drugs       Date:  2010       Impact factor: 3.571

Review 2.  Adverse effects of bisphosphonates: implications for osteoporosis management.

Authors:  Kurt A Kennel; Matthew T Drake
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 3.  Drug-induced atrial fibrillation.

Authors:  Yaman Kaakeh; Brian R Overholser; John C Lopshire; James E Tisdale
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.